Company Name AveXis
Mailing Address 4925 Greenville Avenue Dallas, TX 75206 USA
Company Description Based in Dallas, Texas, AveXis is a clinic-ready, synthetic biology platform company. AveXis has, at its core, a desire to establish unique industry and research alliances which will bring innovative treatments to people with unmet medical needs. Our work in spinal muscular atrophy (SMA), a rare/orphan disease, is our first focus.
Proceeds Purposes Proceeds from the financing will be used to further the development of the Company’s gene therapy product, chariSMATM, including additional support for the current Phase I clinical trial in SMA Type 1 infants.